Emergent Biosolutions Inc (NYSE:EBS) does about 5.49M shares in volume on a normal day but saw 18789210 shares change hands in Friday trading. The company now has a market cap of 203.84M USD. Its current market price is $3.89, marking an increase of 17.88% compared to the previous close of $3.30. The 52 week high reached by this stock is $10.88 whilst the lowest price level in 52 weeks is $1.42.
Emergent Biosolutions Inc (EBS) has a 20-day trading average at $2.21 and the current price is -64.25% off the 52-week high compared with 173.94% distance from its 52-week low. The 50-day simple moving average of the closing price is $2.48 and its 200-day simple moving average is $3.02. If we look at the stock’s price movements over the week, volatility stands at 21.66%, which decreases to 11.30% over 1 month. It is also key to look at other market indicators of price movement for the stock, where we see that the relative strength index (RSI) is at 78.63 to suggest the stock is overbought.
The consensus objective for the share price is $5.00, suggesting that the stock has a potential upside of 22.2% over the period.
The company shares received a number of brokerage firm price updates over the past month, with the latest being on March 07, 2024 when The Benchmark Company upgraded the stock to “Buy” and issued a price target of $5.
Emergent Biosolutions Inc (EBS) stock is up 102.60% over the week and 71.37% over the past month. Its price is 62.08% year-to-date and -53.91% over the past year.
To reach the target analysts have set, the stock logically needs to grow 22.2 percent from here.
The company has a return on investment of -50.30% and return on equity of -60.56%. The beta has a value of 1.17. Price to book ratio is 0.31 and price to sales ratio is 0.17.
